Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
China Pharmacy ; (12): 1816-1823, 2020.
Artigo em Chinês | WPRIM | ID: wpr-823350

RESUMO

OBJECTIVE:To study the mechanism of Periplaneta americana extract degreasing cream and CⅡ-3(shorted for “degreasing cream ”and“CⅡ-3”)reversing the multi-drug resistance of human HepG 2/ADM cells. METHODS :MTT assay was used to investigate the toxicity effects of different concentrations of sorafenib (positive control ),degreasing cream and C Ⅱ-3 on HepG2/ADM cells ,then IC 20 was calculated. The experiment was divided into sensitivity drug ,drug-resistance group ,sorafenib group,degreasing cream group and C Ⅱ-3 group. HepG 2 cells were included in sensitivity group ,and HepG 2/ADM cells were included in the latter 4 groups. Sensitivity group and drug-resistance group were treated with routine medium ,and other 3 groups were treated with relevant medicine (IC20 as drug concentration ). The content of ADM in HepG 2/ADM cells was determined by Laser scanning confocal microscopy. The expression of apoptosis-related protein as Bcl- 2 and Cleaved-Caspase- 9 p37 were detected by Western blotting assay. RT-qPCR and immunocytochemistry were adopted to detect mRNA and protein expressions that related to multidrug resistance [P-gp (expression produce of MDR1 gene),LRP,BCRP] and that related to enzyme-mediated multidrug resistance pathway (GST-π and Topo Ⅱ). RESULTS :The IC 20 of degreasing cream ,CⅡ-3 and sorafenib were (2.40±0.16), (200.44±27.52),(18.00±1.82)μg/mL,respectively. Compared with sensitivity group ,the protein expressions of Bcl- 2,P-gp, LRP,BCRP and Topo Ⅱ,the mRNA expressions of MDR 1, LRP,BCRP and GST-π were increased significantly in drug resistance group (P<0.05 or P<0.01). Compared with @qq.com drug-resistance group ,the mRNA and protein expression of MDR1 mRNA and LRP ,BCRP,GST-π were significantly decreased in degreasing cream group and C Ⅱ-3 group(P< 0.05 or P<0.01);the protein expression of Bcl- 2 and the mRNA expression of Topo Ⅱ were significantly decreased (P<0.01), while the protein expression level of Cleaved-Caspase- 9 p37 was significantly increased in C Ⅱ -3 group (P<0.05). CONCLUSIONS:Degreasing cream and C Ⅱ-3 can reverse multidrug resistance of HepG 2/ADM cells by reducing drug efflux , promoting cell apoptosis ,reducing the mRNA and protein expression of multi-drug resistance gene as well as gene in enzyme-mediated multi-drug resistance pathway. The effect of C Ⅱ-3 is better than that of degreasing cream.

2.
China Pharmacy ; (12): 927-931, 2019.
Artigo em Chinês | WPRIM | ID: wpr-817016

RESUMO

OBJECTIVE: To investigate anti-tumor effects of Periplaneta americana polypeptide PAP-2 on H22 tumor-bearing mice. METHODS: The mice tumor-bearing model was established by subcutaneous injection of ascites of H22 hepatocellular carcinoma mice via axilla. 70 mice were randomly divided into model group (normal saline), 5-FU group (positive drug control, 20 mg/kg), P. americana extract skimmed cream group (200 mg/kg, calculated by extract), CⅡ-3 group (polypeptide isolated from skimmed cream as main active ingredient, 200 mg/kg, calculated by extract) and polypeptide PAP-2 high-dose, medium-dose and low-dose groups (isolated from CⅡ-3, 200, 100, 50 mg/kg, calculated by monomer), with 10 mice in each group. The mice in the 5-FU group were given intraperitoneal injection once every other day, while the mice in the other groups were given intragastric administration once a day, the administration cycle was 10 d. After medication, the changes of tumor were observed and the organs (spleen, thymus and liver) index were measured. Histopathological changes of tumor tissue were observed after HE staining. The contents of VEGF, IL-1β and IL-4 in serum were determined by ELISA. RESULTS: Skimmed cream, CⅡ-3 and different doses of PAP-2 could inhibit the growth of tumor in tumor-bearing mice to different extent and increase organ index, and PAP-2 showed a dose-effect relationship. The tumor inhibition rate (38.95%) of PAP-2 high dose group was significantly higher than those of skimmed cream group and CⅡ-3 group (P<0.05), which was close to that (40.87%) of 5-FU group (P>0.05). Spleen index, thymus index and liver index of mice in PAP-2 high dose group were significantly those of model group and CⅡ-3 group (P<0.05); and the liver index of mice in PAP-2 high dose group was significantly higher than that of skimmed cream group (P<0.05). In addition, PAP-2 could decrease the serum contents of VEGF and IL-4, and increased serum content of IL-1β, with high dose group showed significant difference compared with model group (P<0.05); the serum content of IL-1β of mice in PAP-2 high dose group was significantly higher the that of skimmed cream group and CⅡ-3 group (P<0.05), serum contnet of IL-4 in PAP-2 high dose group was significantly lower the  that of skimmed cream group and CⅡ-3 group (P<0.05), but the serum content in which was significantly lower than that of skimmed cream group and CⅡ-3 group(P<0.05). CONCLU- SIONS: P. americana polypeptide PAP-2 it has a certern anti-tumor effects on H22 tumor-bearing mice, and its can increase the index of organs of H22 tumor-bearing mice, decrease the contents of VEGF and IL-4 in serum, increase the content of IL-1β in serum.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA